Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Allergy and Immunology · Chronic Spontaneous Urticaria

The Biology of CSU: Why Your Body Is Reacting to Itself

At a Glance

Chronic Spontaneous Urticaria (CSU) occurs when the immune system mistakenly triggers mast cells in the skin to release histamine, causing chronic hives without an external allergen. This internal miscommunication can be driven by autoallergic (Type I) or autoimmune (Type IIb) pathways.

To understand CSU, you must first understand the mast cell. Think of these cells as “security guards” stationed throughout your skin [1]. Their job is to protect you by releasing chemicals—primarily histamine—when they detect a threat [2].

In a normal allergy, the “threat” is something external, like peanut protein or cat dander. In Chronic Spontaneous Urticaria, these security guards are being told to fire their alarms (release histamine) by your own immune system, even though no external threat is present [3][4]. This internal “miscommunication” is what leads to the redness, itching, and swelling you experience [2].

The Two Pathways: Type I and Type IIb

While every CSU patient experiences similar hives, the biological “glitch” causing them can happen in two different ways. Doctors call these endotypes [5].

Type I: The “Autoallergic” Pathway (IgE)

In this version, your body produces IgE antibodies (the same type involved in standard allergies) that mistakenly target your own internal proteins instead of external allergens [5].

  • The Glitch: Your immune system creates a “self-allergy.” It treats normal parts of your body as if they were dangerous invaders [6].
  • Treatment Response: Patients with this type often respond very well and very quickly to treatments that block IgE, such as omalizumab [5].

Type IIb: The “Autoimmune” Pathway (IgG)

In this more complex version, your body produces IgG antibodies that directly attack the mast cells themselves [7][8].

  • The Glitch: These antibodies act like a master key that forcedly unlocks the mast cell, causing it to dump histamine into your skin [9].
  • Treatment Response: This type is often associated with more severe symptoms and may take longer to respond to standard treatments [6][10].

The Thyroid Connection

You may notice your doctor checking your thyroid or asking about anti-TPO antibodies. There is a strong link between CSU and autoimmune thyroid conditions, such as Hashimoto’s disease [11].

Having these thyroid antibodies does not necessarily mean your thyroid is failing, but it serves as a “marker” for doctors [10]. It tells them that your immune system is in an autoimmune state, which makes the Type IIb (Autoimmune) pathway more likely [12].

Do I Need Extensive Testing?

It is natural to want a blood test that “proves” which type you have. However, current international guidelines do not recommend extensive lab work for most patients [13][14].

Because the initial treatment—high-dose antihistamines—is the same for both types, doctors usually focus on your symptoms and how you respond to medication rather than expensive biological testing [14]. Extensive testing is generally reserved for cases that do not respond to standard therapy [13]. Instead, your doctor will likely use the UAS7 (Urticaria Activity Score), a daily diary of your hives and itch, to guide your care [15].

Back to Home

Common questions in this guide

Why am I getting hives if I don't have an allergy?
In Chronic Spontaneous Urticaria, your immune system mistakenly tells the mast cells in your skin to release histamine, even when there is no external threat. This internal miscommunication is what causes the redness, swelling, and severe itching of hives.
What is the difference between Type I and Type IIb CSU?
Type I CSU is an autoallergic reaction where your immune system attacks its own normal proteins. Type IIb is an autoimmune pathway where antibodies act like a key, directly unlocking and attacking mast cells to force them to release histamine.
Why did my doctor check my thyroid for chronic hives?
There is a strong connection between CSU and autoimmune thyroid conditions like Hashimoto's disease. Having thyroid antibodies tells doctors that your immune system is in an autoimmune state, which makes the Type IIb pathway more likely.
Do I need special blood tests to find out which type of CSU I have?
Current guidelines usually do not recommend extensive blood work right away. Because the initial treatment is the same for both types of CSU, doctors focus on tracking your symptoms and seeing how you respond to standard antihistamines before ordering specialized tests.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms, do you suspect I have the 'autoallergic' (Type I) or 'autoimmune' (Type IIb) subtype of CSU?
  2. 2.Should we test my anti-TPO antibody levels to see if there is an autoimmune connection to my thyroid?
  3. 3.If I have the Type IIb subtype, does that change how quickly we should expect me to respond to treatment?
  4. 4.Are there specific biomarkers we should monitor to track my mast cell activity over time?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    T Cell/Mast Cell Crosstalk in the Skin of Patients Suffering From Immune-Mediated Diseases, Focusing on Chronic Spontaneous Urticaria.

    Toubi E, Mubariki R, Vadasz Z

    Clinical and translational allergy 2026; (16(1)):e70145 doi:10.1002/clt2.70145.

    PMID: 41462561
  2. 2

    Evidence for bradykinin release in chronic spontaneous urticaria.

    Hofman ZLM, van den Elzen MT, Kuijpers J, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2020; (50(3)):343-351 doi:10.1111/cea.13558.

    PMID: 31899843
  3. 3

    The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.

    Maurer M, Zuberbier T, Metz M

    Handbook of experimental pharmacology 2022; (268()):117-133 doi:10.1007/164_2021_506.

    PMID: 34247278
  4. 4

    Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.

    Maurer M, Casale TB, Saini SS, et al.

    Dermatology and therapy 2024; (14(9)):2427-2441 doi:10.1007/s13555-024-01231-y.

    PMID: 39066978
  5. 5

    Autoimmune chronic spontaneous urticaria.

    Kolkhir P, Muñoz M, Asero R, et al.

    The Journal of allergy and clinical immunology 2022; (149(6)):1819-1831 doi:10.1016/j.jaci.2022.04.010.

    PMID: 35667749
  6. 6

    Biomarkers of Autoimmune Chronic Spontaneous Urticaria.

    Larenas-Linnemann D

    Current allergy and asthma reports 2023; (23(12)):655-664 doi:10.1007/s11882-023-01117-7.

    PMID: 38064133
  7. 7

    Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.

    Schoepke N, Asero R, Ellrich A, et al.

    Allergy 2019; (74(12)):2427-2436 doi:10.1111/all.13949.

    PMID: 31228881
  8. 8

    Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria.

    Jang JH, Moon J, Yang EM, et al.

    PloS one 2022; (17(8)):e0273415 doi:10.1371/journal.pone.0273415.

    PMID: 35984815
  9. 9

    Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions.

    Baumann K, Marcelino J, Skov PS, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(6)):1338-1345 doi:10.1111/jdv.17131.

    PMID: 33475206
  10. 10

    Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria.

    Kolkhir P, Altrichter S, Asero R, et al.

    Allergy, asthma & immunology research 2021; (13(4)):545-559 doi:10.4168/aair.2021.13.4.545.

    PMID: 34212543
  11. 11

    Study on Autoimmune Thyroid Disorders in Chronic Spontaneous Urticaria at a Tertiary Care Central Rural Hospital in India.

    Pendam M, Madke B, Singh A, Jawade S

    Cureus 2023; (15(5)):e39398 doi:10.7759/cureus.39398.

    PMID: 37378208
  12. 12

    Comparison of immunoglobulin E anti-thyroid peroxidase antibodies in patients with Hashimoto thyroiditis and chronic spontaneous urticaria.

    Çildağ S, Yenisey Ç, Ünübol M, Şentürk T

    Medicine and pharmacy reports 2021; (94(1)):53-57 doi:10.15386/mpr-1598.

    PMID: 33629049
  13. 13

    The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.

    Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al.

    Allergy 2022; (77(3)):734-766 doi:10.1111/all.15090.

    PMID: 34536239
  14. 14

    Key differences between chronic inducible and spontaneous urticaria.

    Bizjak M, Košnik M

    Frontiers in allergy 2024; (5()):1487831 doi:10.3389/falgy.2024.1487831.

    PMID: 39483682
  15. 15

    The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.

    Tawil S, Irani C, Kfoury R, et al.

    International journal of dermatology 2020; (59(8)):893-901 doi:10.1111/ijd.15006.

    PMID: 32638368

This page explains the biology and immune pathways of Chronic Spontaneous Urticaria for educational purposes only. Always consult your allergist or dermatologist for a professional medical diagnosis and treatment plan.

Get notified when new evidence is published on chronic idiopathic urticaria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.